2017 Section 7 Green Book
Original Investigation Research
Robotic Surgery Alone in Oropharyngeal Cancer
Table 1. Characteristics of the Study Population Characteristic
Figure 1. Trends in 3 Global Quality-of-Life (QOL) Scale Scores Across 24 Months
No. (%)
Patient Male sex
100
HR QOL compared with 1 mo before diagnosis Overall QOL HR QOL in past 7 d
26 (76)
Age, mean (SD), y
59 (8)
80
a
Race
White
32 (94)
60
African American
2 (6)
History
40
Smoking
24 (70) 20 (59)
Mean QOL Score
20
Alcohol use a
Disease Primary site Tonsil
0
16 (47) 15 (44)
1
12 Postoperative Time, mo 6
24
Tongue base Soft palate
8
12
8
9
No. of patients
2 (6) 1 (3)
Pharyngeal wall
related QOL during the past 7 days,” and “overall QOL includ- ingpersonalwell-beingoverthepast7days”)showedatendency toimprovethroughoutfollow-up( Figure1 ).Oneintervalreached statistically significant improvement (“health-relatedQOLdur- ing the past 7 days” 6 months after surgery) (Figure 1B and Table 2 ); improvements were observed in several other do- mains, although thesewerenot statistically significant (Figure 1 and Table 2) compared with 1-month follow-up scores. ScoresfortheQOLdomainsofpain,swallowing,activity,and chewingalsotendedtoimprovethroughoutfollow-up( Figure2 ). Statisticallysignificantimprovementinchewingscoreswasnoted from1 to 12months after surgery ( P = .048) (Figure 2B). A posi- tive trendwas observed for chewing scores over time ( P = .05). Painscoresimprovedfrom1to6months( P = .006)and12months ( P = .01) after surgery (Figure 2C). However, there was no evi- dencethatthemedianpainscorecontinuedtoimproveovertime ( P = .10). Swallowing scores improved from 1 to 6months ( P = .047) and 24months ( P = .048) after surgery (Figure 2D). There wasanoverallpositivetrendinswallowingscores( P = .01).Inad- dition, the median activity score improved over time ( P = .03) (Figure 2A). Noother specific symptomdomains showed statis- tical evidence of improvement or deterioration from 1 month after surgery over time ( Table 3 ). Discussion Increasing recognition of the adverse effects of CRT and their negative effect on QOL has provided the rationale for TORS as a primary treatment modality option for OPSCC. The present study is especially timely in the current era of human papil- loma virus–positive OPSCC, with younger and healthier pa- tients seeking treatment modalities with less long-term treat- ment-relatedmorbidity.Thereis,however,apaucityofliterature describing the long-term QOL of patients who receive TORS Health-related (HR) QOL compared with 1 month before cancer diagnosis, during the past 7 days ( P = .01 at 6 months), and overall QOL, including personal well-being, during the past 7 days. a P < .05 compared with 1 month after surgery.
Extracapsular spread Yes
4 (12)
No
15 (44) 15 (44)
Not evaluated
T category T1
20 (59) 13 (38)
T2 T3
1 (3)
N category N0
13 (38) 16 (47)
N1
N2a N2b
3 (9) 2 (6)
p16 Status Positive
25 (74)
Negative
8 (24)
Not evaluated
1 (3)
Perineural invasion Positive margins
4 (12)
Follow-up The follow-up period for overall survival was defined as the number ofmonths fromthe date of TORS to the date of the last follow-up determined by clinic visit, telephone survey, or death. Mean follow-up for this cohort was 14 months (range, 13 days to 38months; fromMay 1, 2010, to April 30, 2014). Two patients (6%) died during the follow-up period: 1 due to dis- ease and 1 due to a myocardial infarction. There were no in- traoperative complications. Two patients (6%) required tem- porary gastrostomy tube placement, but no patients required tracheostomy. Among all the completed UW-QOL forms, 4 forms were completed preoperatively, 8 at 1 month after sur- gery, 12 at 6 months, 8 at 12 months, and 9 at 24 months. Quality of Life The scores for the 3 global QOL survey questions (“health- related QOL compared to 1 month before cancer,” “health- 1 (3) a History of alcohol use was defined as any “regular use of alcohol” on the self-reported University of Washington Quality of Life, version 4, survey.
(Reprinted) JAMA Otolaryngology–Head & Neck Surgery June 2015 Volume 141, Number 6
jamaotolaryngology.com
Copyright 2015 American Medical Association. All rights reserved.
155
Made with FlippingBook